August 30, 2016 5:04 AM ET

Biotechnology

Company Overview of Alkermes plc

Executive Profile

Richard F. Pops

Chairman and Chief Executive Officer, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 5 different industries.

See Board Relationships
54$12,407,489
As of Fiscal Year 2015

Background

Mr. Richard F. Pops has been the Chief Executive Officer at Alkermes PLC since September 11, 2009. Mr. Pops founded Genomics Collaborative, Inc. He Co-Founded Sirtris Pharmaceuticals, Inc. He served as the President of Alkermes PLC from September 11, 2009 to September 16, 2011 and previously served as its Chief Executive Officer from February 1991 to April 1, 2007. He was employed by PaineWebber Development Corporation as a Vice President. He has been the Chairman at ...

Corporate Headquarters

Connaught House
Dublin, Co. Dublin D04 C5Y6

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships

Director At Large
Director
Trustee
Director
1991-Present
Chairman and Chief Executive Officer
1998-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2004-Present
Director and Member of Nominating & Corporate Governance Committee
2008-Present
Independent Director and Member of Audit Committee

Education

BA 1983
Stanford University

Other Affiliations

Annual Compensation

Salary$881,019
Total Annual Compensation$881,019

Stocks Options

Restricted Stock Awards$2,849,200
All Other Compensation$13,250
Exercised Options$187,500
Exercised Options Value$9,770,925
Exercisable Options$2,523,750
Exercisable Options Value$161,370,988
Unexercisable Options$635,000
Unexercisable Options Value$21,105,325
Total Value of Options$192,247,237
Total Number of Options$3,346,250

Total Compensation

Total Annual Cash Compensation$2,659,689
Total Short Term Compensation$881,019
Other Long Term Compensation$2,862,450
Total Calculated Compensation$12,407,489
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
$1.0M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$869.6K
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals PLC
$4.1M
Leon O. Moulder Jr., M.B.A.Co-Founder, Chief Executive Officer and Director
Tesaro, Inc.
$618.1K
Shaun Thaxter Chief Executive Officer and Director
Indivior PLC
$2.1M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alkermes plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.